Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?

Despite the availability of treatment guidelines and inhaled medications for asthma and chronic obstructive pulmonary disease (COPD), much remains to be done to lessen the burden of these respiratory diseases for patients. The challenge of selecting effective and efficacious drugs for patients is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Leather, David A., Yates, Louisa, Svedsater, Henrik, Jacques, Loretta, Collier, Susan, Powell, Danielle, Jones, Rupert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679431/
https://www.ncbi.nlm.nih.gov/pubmed/31375102
http://dx.doi.org/10.1186/s12931-019-1127-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679431/
https://www.ncbi.nlm.nih.gov/pubmed/31375102
http://dx.doi.org/10.1186/s12931-019-1127-6

Ejemplares similares